NCT05038592 2026-01-21Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic SyndromesM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting64 enrolled